ConductScience.org, home

Paper43165

Clinical pharmacology of labetalol.

Richards DA and 1 other. Br J Clin Pharmacol, 1979. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. Clinical pharmacology of labetalol. Papers, record 43165. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/43165

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical pharmacology of labetalol.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
3.09
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Richards DAD A
2Prichard BNB N

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EthanolaminesMajor topic
LabetalolMajor topic
Adrenergic alpha-Antagonists
Adrenergic beta-Antagonists
Hemodynamics
Humans
Kinetics
Sympathetic Nervous System

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14850484Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.Br Heart J1974https://conductscience.org/library/papers/4850484PubMed
2444356Circulatory effects of noradrenaline and adrenaline before and after labetalol.Br J Clin Pharmacol1979https://conductscience.org/library/papers/444356PubMed
3791328Haemodynamic effects of long-term oral labetalol.Br J Clin Pharmacol1976https://conductscience.org/library/papers/791328PubMed
4802650Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.Clin Sci Mol Med Suppl1975https://conductscience.org/library/papers/802650PubMed
5843418Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise.Br J Clin Pharmacol1977https://conductscience.org/library/papers/843418PubMed
6851058Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients.Am Heart J1977https://conductscience.org/library/papers/851058PubMed
7861131Effects of labetalol and propranolol on histamine-induced bronchoconstriction in normal subjects.Br J Clin Pharmacol1977https://conductscience.org/library/papers/861131PubMed
8901713Modification of pressor responses induced by 'cold' [proceedings].Br J Clin Pharmacol1977https://conductscience.org/library/papers/901713PubMed
9990152Metabolism of labetalol by animals and man.Br J Clin Pharmacol1976https://conductscience.org/library/papers/990152PubMed
109968Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.Br J Clin Pharmacol1976https://conductscience.org/library/papers/9968PubMed
1110949Pharmacological effects of labetalol in man.Br J Clin Pharmacol1976https://conductscience.org/library/papers/10949PubMed
1212778Pharmacological basis for antihypertensive effects of intravenous labetalol.Br Heart J1977https://conductscience.org/library/papers/12778PubMed
1312880Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.Circulation1977https://conductscience.org/library/papers/12880PubMed
1414010Relationship between plasma concentrations and pharmacological effects of labetalol.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/14010PubMed
1515698The effects of labetalol (AH 5158) on adrenergic transmission in the cat spleen.Br J Pharmacol1977https://conductscience.org/library/papers/15698PubMed
1620123The assessment of beta-adrenoceptor blocking drugs in man.Br J Clin Pharmacol1977https://conductscience.org/library/papers/20123PubMed
17236806Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma.Br Med J1975https://conductscience.org/library/papers/236806PubMed
1826370The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.Br J Clin Pharmacol1978https://conductscience.org/library/papers/26370PubMed
1926372Circulatory and alpha-adrenoceptor blocking effects of phentolamine.Br J Clin Pharmacol1978https://conductscience.org/library/papers/26372PubMed
2028869Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol.Clin Pharmacol Ther1978https://conductscience.org/library/papers/28869PubMed

See all 27 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
42722786Self-Nanoemulsifying Drug Delivery Systems for Cardiovascular Therapeutics: Formulation Strategies, Pharmacokinetic Enhancement and Precision-Oriented Translation.J Cardiovasc Transl Res2026https://conductscience.org/library/papers/42722786PubMed
41694034Efficacy of nitroglycerin vs labetalol in hypertensive emergency among patients with a history of coronary artery disease.World J Cardiol2026https://conductscience.org/library/papers/41694034PubMed
34732465Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.J Neurol Neurosurg Psychiatry2022https://conductscience.org/library/papers/34732465PubMed
32709242Retrospective evaluation of labetalol as antihypertensive agent in dogs.BMC Vet Res2020https://conductscience.org/library/papers/32709242PubMed
32303182Effects of nitroglycerin versus labetalol on peripheral perfusion during deliberate hypotension for sinus endoscopic surgery: a randomized, controlled, double-blinded trial.BMC Anesthesiol2020https://conductscience.org/library/papers/32303182PubMed
29974290Neurogenic hypertension: pathophysiology, diagnosis and management.Clin Auton Res2018https://conductscience.org/library/papers/29974290PubMed
26370555Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies.Curr Cardiol Rep2015https://conductscience.org/library/papers/26370555PubMed
23090703CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects.Eur J Clin Pharmacol2013https://conductscience.org/library/papers/23090703PubMed
22458739A simplified mechanistic algorithm for treating resistant hypertension: efficacy in a retrospective study.J Clin Hypertens (Greenwich)2012https://conductscience.org/library/papers/22458739PubMed
19751461The clinical spectrum of labile hypertension: a management dilemma.J Clin Hypertens (Greenwich)2009https://conductscience.org/library/papers/19751461PubMed
11821634Psychological characteristics and responses to antihypertensive drug therapy.J Clin Hypertens (Greenwich)2002https://conductscience.org/library/papers/11821634PubMed
8527263The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.Br J Clin Pharmacol1995https://conductscience.org/library/papers/8527263PubMed
7295464Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7295464PubMed
7082539Rapid reduction of blood pressure with acute oral labetalol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7082539PubMed
7049710Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7049710PubMed
6846084Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions.Acta Neurochir (Wien)1983https://conductscience.org/library/papers/6846084PubMed
6615664Metabolic and haemodynamic effects of increased circulating adrenaline in man. Effect of labetalol, an alpha and beta blocker.Br Heart J1983https://conductscience.org/library/papers/6615664PubMed
6151893Combined receptor intervention and myocardial infarction.Drugs1984https://conductscience.org/library/papers/6151893PubMed
6151891Combined alpha- and beta-receptor inhibition in the treatment of hypertension.Drugs1984https://conductscience.org/library/papers/6151891PubMed
6124265Comparison of labetalol with other anti-hypertensive drugs.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6124265PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/43165

GET https://conductscience.org/api/papers/v1/43165/references?page=2